Malaysian Drug Makers See Sales Passing $1 Billion By Year's End
This article was originally published in PharmAsia News
Executive Summary
Malaysia's pharmaceutical industry is expected to pass the $1 billion market by the end of this year, up 10 percent from 2008. Sales are projected at $1.1 billion, thanks primarily to the threatening H1N1 flu pandemic driving higher demand for drugs. Malaysia's drug makers also were less affected by the global economic crisis than were other industries. Jimmy Piong, president of the Malaysian Organization of Pharmaceutical Industries, said the rise in demand for H1N1 medicines offset declining sales of over-the-counter drugs at the same time sales of prescription drugs remained steady, with generics accounting for 35 percent of the Malaysian market. (Click here for more